tm
Seeing Is Believing
tm
Seeing Is Believing
GRTS is currently covered by 4 analysts
Gritstone Oncology's activity chart (see below) currently has 4 price targets and 13 ratings on display. The stock rating distribution of GRTS is 90.91% BUY and 9.09% SELL.
Analysts average stock forecasts to be materialized ratio is 27.38% with an average time for these price targets to be met of 73.33 days.
Highest price target for GRTS is $4, Lowest price target is $1.
Most recent stock forecast was given by MAYANK MAMTANI from B. RILEY on 07-Dec-2023. First documented stock forecast 11-Dec-2018.
Currently out of the existing stock ratings of GRTS, 10 are a BUY (90.91%), 1 are a SELL (9.09%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$6
$4.99 (494.06%)
$8
2 years 10 months 19 days ago
(07-Dec-2023)
0/2 (0%)
$4.38 (270.37%)
Buy
$7
$5.99 (593.07%)
$6
3 years 28 days ago
(28-Sep-2023)
0/2 (0%)
$5.44 (348.72%)
Buy
$7
$5.99 (593.07%)
$7
3 years 2 months 16 days ago
(10-Aug-2023)
1/7 (14.29%)
$5.18 (284.62%)
5
Sell
$2
$0.99 (98.02%)
$15
4 years 2 months 4 days ago
(22-Aug-2022)
1/2 (50%)
$-1.74 (-46.52%)
267
Buy
$35
5 years 11 days ago
(15-Oct-2021)
0/2 (0%)
$9.45 (36.99%)
What is GRTS (Gritstone Oncology) average time for price targets to be met?
Which analyst most recently updated their price target on GRTS (Gritstone Oncology)?
Which analyst has the current lower performing score on GRTS (Gritstone Oncology) with a proven track record?
Which analyst has the most public recommendations on GRTS (Gritstone Oncology)?
Which analyst is the currently most bullish on GRTS (Gritstone Oncology)?
Which analyst is the currently most reserved on GRTS (Gritstone Oncology)?
